Skip to main content
Loading Events

« All Events

Colloquium Series: Dr. Michael J Cima, Massachusetts Institute of Technology

Tuesday, April 11 @ 4:00 pm - 5:00 pm

Join us for our Colloquium Series. Dr. Michael J Cima, a research professor at MIT will be joining us to present his research on Translational Biomedical Engineering at Chapman Hall, Room 125.

Research Synopsis

This talk will discuss my journey from materials science and engineering to medicine through a series of technologies originating in my lab. Mostly, it’s a reflection on where these ideas came from. There are three key themes; pivot, adjacency, and theory of change.
 
Topics will include:

  • the role of materials in pharmaceutical development
  • magnetics in diagnostics
  • single compartment drug targeting
  • hydration status measurement

Biography

Cima Labs

Dr. Michael J. Cima is a Professor of Materials Science and Engineering at the Massachusetts Institute of Technology and has an appointment at the David H. Koch Institute for Integrative Cancer Research. Professor Cima joined the MIT faculty in 1986 and has received numerous awards. He was elected to the National Academy of Engineering in 2011 and to the National Academy of Inventors in 2016.

He now holds the David H. Koch Chair of Engineering at MIT. He was appointed faculty director of the Lemelson-MIT Program in 2009 which is a program to inspire youth to be inventive and has a nationwide reach. He was appointed Associate Dean of Engineering in 2018 and co-director of the MIT Innovation Initiative. Prof. Cima is author or co-author of over three hundred peer reviewed scientific publications, ninety US patents, and is a recognized expert in the field of medical devices and materials processing. Prof. Cima has been very active in the translation of new technologies in to the clinic, including a new therapy for bladder cancer.

Details

Date:
Tuesday, April 11
Time:
4:00 pm - 5:00 pm
Event Category:

Venue

Chapman Hall, Room 125
Chapel Hill, NC 27599 United States + Google Map
Comments are closed.